Furthermore, our results suggest the potential mechanism of HE’s neuroprotective function may be through the inhibition of MLK3 phosphorylation, which activates the NF-kB and MEK4/7-JNK pathways (Figure 8). The gene discussed is MAP3K11; the disease is hereditary elliptocytosis.